Disease Areas / Therapeutic Areas
Deep Expertise Across Diverse Therapeutic Areas
Our team brings specialised preclinical knowledge to a broad range of disease areas, ensuring your program benefits from targeted, disease-specific expertise.
Targeted Expertise for Your Therapeutic Area
Preclinical development is not one-size-fits-all. Each disease area presents unique biological challenges, regulatory considerations, and model requirements. vivoPharm's specialists bring deep, focused expertise to your specific therapeutic target.
Oncology
Comprehensive preclinical oncology expertise spanning solid tumours, haematological malignancies, and immuno-oncology. We guide compound evaluation from cell-based assays through xenograft and syngeneic models to IND-enabling studies.
Central Nervous System (CNS)
Specialised CNS preclinical consulting covering neurodegenerative diseases, psychiatric disorders, pain, and rare neurological conditions. Expert guidance on BBB penetration, CNS safety pharmacology, and disease-relevant models.
Cardiovascular & Metabolic
Expert preclinical strategy for cardiovascular diseases, metabolic disorders, and cardiometabolic conditions. Comprehensive safety pharmacology and efficacy model guidance.
Immunology & Inflammation
Deep expertise in autoimmune diseases, inflammatory conditions, and immunomodulatory therapeutics. Guidance on relevant animal models, biomarker selection, and translational strategies.
Infectious Disease
Preclinical consulting for antibacterial, antiviral, and antifungal programs. Expert guidance on in vitro and in vivo infection models, PK/PD relationships, and resistance strategies.
Rare & Orphan Diseases
Specialised support for rare disease programs, including guidance on small patient populations, natural history studies, and regulatory incentives such as orphan drug designation.
Respiratory
Preclinical expertise for respiratory diseases including asthma, COPD, pulmonary fibrosis, and lung cancer. Guidance on inhalation toxicology, lung models, and translational endpoints.
Fibrosis & Liver Disease
Expert preclinical consulting for hepatic and fibrotic conditions, including NASH, NAFLD, and liver fibrosis. Guidance on relevant biomarkers, histopathology endpoints, and translational models.
Don't See Your Therapeutic Area?
Our network of specialist advisors covers virtually every disease area. Contact us to discuss your specific program.
Contact Our Experts